The estimated Net Worth of John W. Sayward is at least $74.3 millier dollars as of 16 August 2020. Mr. Sayward owns over 1,250 units of Digirad Corp stock worth over $74,309 and over the last 16 years he sold DRAD stock worth over $0. In addition, he makes $0 as Independent Director at Digirad Corp.
Sign up
Mr. Sayward DRAD stock SEC Form 4 insiders trading
John has made over 4 trades of the Digirad Corp stock since 2009, according to the Form 4 filled with the SEC. Most recently he exercised 1,250 units of DRAD stock worth $4,488 on 16 August 2020.
The largest trade he's ever made was buying 7,000 units of Digirad Corp stock on 17 February 2009 worth over $7,280. On average, John trades about 885 units every 175 days since 2008. As of 16 August 2020 he still owns at least 20,699 units of Digirad Corp stock.
You can see the complete history of Mr. Sayward stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
John Sayward biography
John W. Sayward serves as Independent Director of the Company. Sayward is a career health care and pharmaceutical executive. Most recently, he served as Chief Executive Officer for Hera Therapeutics Inc., a position he held through June 2015. Prior to this, Mr. Sayward served as the Chief Operating Officer and Chief Financial Officer of Hera Therapeutics Inc. since September 2014. Previously, he was Partner at Nippon Heart Hospital, LLC from September 2005 to January 2007, which was formed to build and manage cardiovascular care hospitals in Japan. From 2002 to 2005, Mr. Sayward was the Executive Vice President and CFO of LMA North America Inc., a medical device business focused on patient airway management. From 1996 to 2001, Mr. Sayward served as the Executive Vice President of Finance and CFO and Treasurer at SICOR Inc., and was elected to their Board of Directors in 1998. Previous to the above, he served in various management positions with Baxter Healthcare. He received a B.A. in History from Northwestern University in 1973 and a Master of Management from the Kellogg School of Management at Northwestern University in 1975. Further, Mr. Sayward’s depth and breadth of positions and experiences also makes him well qualified to serve as a financial expert and audit committee chairman.
How old is John Sayward?
John Sayward is 68, he's been the Independent Director of Digirad Corp since 2008. There are no older and 4 younger executives at Digirad Corp.
What's John Sayward's mailing address?
John's mailing address filed with the SEC is C/O DIGIRAD CORPORATION, 1048 INDUSTRIAL COURT, SUWANEE, GA, 30024.
Insiders trading at Digirad Corp
Over the last 20 years, insiders at Digirad Corp have traded over $838,333 worth of Digirad Corp stock and bought 3,317,814 units worth $9,324,356 . The most active insiders traders include Capital Llc Cannell, Jeffrey E. Eberwein et James B Hawkins. On average, Digirad Corp executives and independent directors trade stock every 18 days with the average trade being worth of $47,966. The most recent stock trade was executed by David J. Noble on 30 November 2020, trading 3,000 units of DRAD stock currently worth $8,910.
What does Digirad Corp's logo look like?
Complete history of Mr. Sayward stock trades at Digirad Corp
Digirad Corp executives and stock owners
Digirad Corp executives and other stock owners filed with the SEC include:
-
Matthew Molchan,
President, Chief Executive Officer, Director -
David Noble,
Chief Financial Officer, Chief Operating Officer -
Martin Shirley,
President - Digirad Imaging Solutions -
Jeffrey Eberwein,
Chairman of the Board -
John Sayward,
Independent Director -
Mitchell Quain,
Independent Director -
Michael Cunnion,
Independent Director -
Raymond William Vogel,
CEO of DMS Health Technologies -
Virgil Lott,
SVP, Operations -
John M Climaco,
Director -
Jeffry R. Keyes,
Chief Financial Officer -
Charles M Gillman,
Director -
Dimitrios Angelis,
Director -
Capital Llc Cannell,
10% owner -
Michael De Beauvernet,
General Manager,Mobile Imaging -
Sarah L. Hanssen,
SVP, Commercial Ops & Bus Dev -
Armando Jackson,
SVP of Product Sales -
Richard B Slansky,
Chief Financial Officer -
Randy Weatherhead,
Vice President of Marketing -
R King Nelson,
Director -
Paul J Early,
VP Corporate Radiation Safety -
Lloyd H Malchow,
Director -
Michael J Keenan,
Pres,Digirad Imaging Solutions -
Raymond V Dittamore,
Director -
Vera P Pardee,
VP, General Counsel & Sec. -
Douglas Md Reed,
Director -
Growth Inc Sorrento,
10% owner -
Associates Lp Kingsbury,
10% owner -
Marc Shapiro,
Sr. VP, Human Resources -
James B Hawkins,
Director -
Steven C Mendell,
Director -
Todd P Clyde,
Chief Financial Officer -
Richard L Conwell,
Sr. VP - Technology -
Associates Inc Sorrento,
10% owner -
David M Sheehan,
President and CEO -
Fund Management Ii Llc Vector,
10% owner -
Kenneth E Olson,
Director -
Gerhard F Burbach,
Director -
Freire Lima,
VP - Clinical Operations -
Fund Management Lp Vector,
10% owner -
Timothy J Wollaeger,
Director -
Mark Casner,
President, Digirad Imaging Sol -
Peter Sullivan,
Senior VP of Operations